The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Akers Biosciences Issues Default Notice To Shareholder ChubeWorkx

Mon, 11th May 2015 08:49

LONDON (Alliance News) - Akers Biosciences Inc said Monday it has served a notice of default to shareholder ChubeWorkx Guernsey Ltd due to it failing to pay on time two instalments under a promissory note, and has filed a suit in the District Court of New Jersey in the US to stop ChubeWorkx from selling its shares in the company.

ChubeWorkx has a 9.97% interest in Akers.

ChubeWorkx issued the promissory note in the aggregate amount of USD1.48 million at the end of 2014. The note was payable in sixty equal instalments, and pays interest of 5% per year. Although Akers did receive the March 1 and April 1 instalments, it has served a notice of default for ChubeWorkx as it failed to pay either instalment in the time period required by the note.

Akers now says ChubeWorkx must immediately satisfy all monies owed and outstanding on the note, amounting to USD1.37 million.

In the event of a default, Akers has the right to require ChubeWorkx to transfer all of its shares back to the company, so Akers said it has filed the suit against ChubeWorkx to enforce this remedy and prevent ChubeWorkx from selling its shares to any third parties.

Shares in Akers are untraded Monday morning. It last closed at 299.00 pence.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.